top of page
The Full Story
iCE Neuro: from conception to clinical application
May 2018
iCE Neuro launches with $700,000 in startup funds.
March 2020
FDA grants Emergency Use authorization for use of the iCEWav Neuromonitoring Platform with subcutaneous electrodes for a critically ill COVID patient.
April 2020
FDA grants 510(k) clearance for the iCEWav Neuromonitoring software platform.
March-June 2020
iCEWav becomes an integral component of care for critically ill COVID patients.
November 2020
iCE Neuro completes landmark trial of iCE-SG electrodes in patients with cardiac arrest.
January 2021
iCE Neuro raises $2.95M in seed funding to accelerate clinical adoption and catalyze big-data analysis.
February 2021
FDA grants 510(k) clearance for iCE-SG Subcutaneous Electrode arrays.
bottom of page